TH1501007498A - Stable crystalline form of tipiracil hydrochloride. and crystallization methods for the same substances - Google Patents

Stable crystalline form of tipiracil hydrochloride. and crystallization methods for the same substances

Info

Publication number
TH1501007498A
TH1501007498A TH1501007498A TH1501007498A TH1501007498A TH 1501007498 A TH1501007498 A TH 1501007498A TH 1501007498 A TH1501007498 A TH 1501007498A TH 1501007498 A TH1501007498 A TH 1501007498A TH 1501007498 A TH1501007498 A TH 1501007498A
Authority
TH
Thailand
Prior art keywords
crystalline form
stable crystalline
crystallization methods
same substances
tipiracil hydrochloride
Prior art date
Application number
TH1501007498A
Other languages
Thai (th)
Other versions
TH163095A (en
TH163095B (en
Inventor
ฮิเดกิ มัตสึมิ โตโมโนบุ คาซูโนะ
Original Assignee
ไตโฮ ฟาร์มาซูติคอล โก แอลทีดี
Filing date
Publication date
Application filed by ไตโฮ ฟาร์มาซูติคอล โก แอลทีดี filed Critical ไตโฮ ฟาร์มาซูติคอล โก แอลทีดี
Publication of TH163095A publication Critical patent/TH163095A/en
Publication of TH1501007498A publication Critical patent/TH1501007498A/en
Publication of TH163095B publication Critical patent/TH163095B/en

Links

Abstract

; ;

TH1501007498A 2014-06-17 Stable crystalline form of tipiracil hydrochloride. And the method of crystallization for the same substance TH163095B (en)

Publications (3)

Publication Number Publication Date
TH163095A TH163095A (en) 2017-06-01
TH1501007498A true TH1501007498A (en) 2017-06-01
TH163095B TH163095B (en) 2017-06-01

Family

ID=

Similar Documents

Publication Publication Date Title
DK3512850T3 (en) INHIBITORS OF THE MENIN-MLL INTERACTION
DK3468966T3 (en) INHIBITORS OF THE MENIN-MLL INTERACTION
DK3492632T3 (en) METHODS FOR THE TREATMENT OF LITHIUM-CONTAINING MATERIALS
DK3298002T3 (en) Heterocyclic amides as kinase inhibitors
DK3192902T3 (en) PROCEDURE FOR THE MANUFACTURE OF GRAPHENCY VISCOSEFIBREES
DK3442972T3 (en) BROMDOMAIN INHIBITORS
DK3560954T3 (en) MODIFIED J-CHAIN
DK3096741T3 (en) PROCEDURE FOR THE PREPARATION OF HYBRIDOSOMES
DK3174858T3 (en) PROCEDURE FOR THE PREPARATION OF PYRAZOLS
CL2016002638A1 (en) New nitrification inhibitors
CU20160125A7 (en) DIACILGLICEROL ACILTRANSFERASA 2 INHIBITORS
IL246385A0 (en) Crystalline forms of afatinib di-maleate
DK3157534T3 (en) ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
DK3191487T3 (en) SPIROCYCLIC CATHEPSIN-C INHIBITORS
DK3341379T3 (en) EZH2 inhibitors
DK3186242T3 (en) ALFA-AMINO-BETA-CARBOXYMUCONSIDE-SEMIALDEHYDE-DECARBOXYLASE INHIBITORS
DK3114120T3 (en) TETRAZOLON SUBSTITUTED DIHYDROPYRIDINON-MGAT2 INHIBITORS
CL2015001019S1 (en) Vial
DE112015003475A5 (en) chuck
DK3498588T3 (en) HOLDING EVENT
DK3481826T3 (en) TYROSINKINASE INHIBITORS
DK3237407T3 (en) 3,5-DIAMINOPYRAZOLKINASE INHIBITORS
EP3212611A4 (en) Crystal forms of verapamil hydrochloride
TH1501007498A (en) Stable crystalline form of tipiracil hydrochloride. and crystallization methods for the same substances
DK3417873T3 (en) THE ULTRARS HYPOALLERGEN SOLUTIONS OF SACROSIDASE